Statewide

Kentucky Board of Emergency Medical Services

Current195 dose entries61 drugs10 documentsKYeffective 2025-04-3093% machine-parsed of 195

Kentucky Board of Emergency Medical Services (KY) carries 61 drugs across 195 dose entries in its current published protocol, effective 2025-04-30.

Drugs and doses61

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	500–1000 mg	PO	not captured	standing	pages 79, 148 · source
Fever	peds	15 mg/kg	PO	not captured	standing	pages 79, 148 · source
Mild to moderate pain	adult	500–1000 mg	PO	not captured	standing	pages 82, 139 · source
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	pages 82, 139 · source

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	pages 67, 69, 295 · source
SVT	peds	0.1–0.2 mg/kg	IV	not captured	standing	pages 67, 69, 295 · source

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 74, 134, 135 · source
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 74, 134, 135 · source
Other	adult	2.5 mg	NEB	not captured	standing	page 395 · source
Other	peds	2.5 mg	NEB	not captured	standing	page 395 · source

Amyl Nitrite

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 ampule	NEB	not captured	standing	page 418 · source
Other	peds	1 ampule	NEB	not captured	standing	page 418 · source

Atox Combopen

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	220 mg	IM	not captured	standing	page 332 · source

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	pages 65, 66, 126, 127 · source
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 65, 66, 126, 127 · source
Nerve agent exposure	adult	2 mg	IM	not captured	standing	pages 89, 90, 410 · source
Organophosphate poisoning	adult	2 mg	IV	not captured	standing	pages 86, 91, 92, 144, 401, 409, 421 · source
Organophosphate poisoning	peds	0.05–0.1 mg/kg	IV	not captured	standing	pages 86, 91, 92, 144, 401, 409, 421 · source

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	5–10 mL	IV	not captured	standing	page 424 · source
Burns	peds	0.1–0.2 mL	IV	not captured	standing	page 424 · source

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	0.5 mL	SQ	not captured	standing	page 423 · source
Burns	adult	10–30 mL	IV	not captured	standing	page 423 · source
Burns	adult	2.5 to 10% gel	TOP	not captured	standing	page 423 · source
Burns	adult	50 mL	not captured	not captured	standing	page 423 · source
Burns	peds	0.2–0.3 mL/kg	IV	not captured	standing	page 423 · source
Burns	peds	0.5 mL	SQ	not captured	standing	page 423 · source
Burns	peds	2.5 to 10% gel	TOP	not captured	standing	page 423 · source
Burns	peds	50 mL	not captured	not captured	standing	page 423 · source
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 301 · source

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	page 196 · source
Trauma / hemorrhage	peds	35 mg/kg	IV	not captured	standing	page 196 · source

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	4 or 5 mg	IV/IO/IM	not captured	standing	pages 112, 161 · source
Adrenal crisis	peds	4 or 5 mg	IV/IO/IM	not captured	standing	pages 112, 161 · source

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	12.5–25 g	IV/IO	not captured	standing	pages 75, 304 · source
Hypoglycemia	peds	0.5–1 g/kg	IV/IO	not captured	standing	pages 75, 304 · source

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IV/IM	not captured	standing	pages 91, 92, 144 · source
Procedural sedation	adult	5–15 mg	IV	not captured	standing	page 305 · source
Procedural sedation	peds	0.05 mg/kg	IV	not captured	standing	page 305 · source
Seizure	adult	5–10 mg	IV	not captured	standing	pages 96, 147, 305 · source
Seizure	peds	0.2–0.5 mg/kg	IV	not captured	standing	pages 96, 147, 305 · source
Seizure	peds	0.5 mg/kg	PR	not captured	standing	page 305 · source

Diazoxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg/kg	IV	not captured	standing	page 306 · source
Other	peds	5 mg/kg	IV	not captured	standing	page 306 · source

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25 mg/kg	IV	not captured	standing	page 307 · source

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/PO	not captured	standing	page 73 · source
Allergic reaction	peds	1 mg/kg	IV/PO	not captured	standing	page 73 · source
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	pages 80, 86 · source

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	2–10 mcg/kg	IV	not captured	standing	page 65 · source
Bradycardia	adult	5–20 mcg/kg	IV	not captured	standing	page 66 · source
Cardiogenic shock	adult	2–20 mcg/kg	IV	not captured	standing	pages 163, 166 · source
Hypotension / shock	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 25 · source

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IM	not captured	standing	page 39 · source
Agitation	adult	2.5 mg	IV	not captured	standing	pages 35, 39 · source
Agitation	adult	2.5 mg	IV	not captured	standing	page 39 · source
Agitation	adult	5–10 mg	IM	not captured	standing	pages 35, 39 · source

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 72, 132 · source
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 72, 132 · source
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 74, 135 · source
Asthma / bronchospasm	peds	0.01 mg/kg	IM	not captured	standing	pages 74, 135 · source
Bradycardia	adult	2–10 mcg	IV	not captured	standing	pages 65, 66 · source
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 62, 123, 124 · source
Cardiac arrest	adult	2–2.5 mg	ET	not captured	standing	page 124 · source
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 62, 123, 124 · source
Hypotension / shock	adult	1–2 mL	IV	not captured	standing	pages 131, 163, 166 · source
Hypotension / shock	peds	1–2 mL	IV	not captured	standing	pages 131, 163, 166 · source

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV	not captured	standing	page 240 · source
RSI induction	peds	0.3 mg/kg	IV	not captured	standing	page 240 · source

Famotidine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	40 mg	IV/PO	not captured	standing	page 73 · source
Allergic reaction	peds	0.25 mg/kg	IV/PO	not captured	standing	page 73 · source

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	25–50 mcg	IV/IM/IN	not captured	standing	page 60 · source
Severe pain	adult	0.5–1 mcg/kg	IV/IM/IN	not captured	standing	pages 83, 140 · source
Severe pain	adult	25–50 mcg	IV/IO/IN	not captured	standing	page 81 · source
Severe pain	peds	0.5–1 mcg/kg	IV/IM/IN	not captured	standing	pages 83, 140 · source
Severe pain	peds	1 mcg/kg	IV/IM/IN	not captured	standing	page 138 · source

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–1 mg/kg	IV	not captured	standing	page 313 · source
Other	peds	1 mg/kg	IV	not captured	standing	page 313 · source

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2–5 mg	IV/IM/SQ	not captured	standing	pages 65, 86, 142 · source
Hypoglycemia	adult	1 mg	IM/SQ	not captured	standing	pages 75, 136 · source
Hypoglycemia	peds	1 mg	IM/SQ	not captured	standing	pages 75, 136 · source

Heparin Sodium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	80 unit/kg	IV	not captured	standing	page 317 · source
Other	peds	50 unit/kg	IV	not captured	standing	page 317 · source

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	pages 112, 161 · source
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 112, 161 · source

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	pages 87, 143, 400, 409 · source
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	pages 87, 143, 400, 409 · source

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	400–800 mg	PO	not captured	standing	pages 79, 148 · source
Fever	peds	10 mg/kg	PO	not captured	standing	pages 79, 148 · source
Mild to moderate pain	adult	400–800 mg	PO	not captured	standing	pages 82, 139 · source
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 82, 139 · source

Insulin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10–25 unit	IV	not captured	standing	page 319 · source
Other	peds	0.1–0.2 unit/kg	IV	not captured	standing	page 319 · source

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 74, 134, 135 · source
Asthma / bronchospasm	peds	0.25 mg	NEB	not captured	standing	pages 74, 134, 135 · source

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1.5 mg/kg	IV	not captured	standing	pages 37, 39 · source
Agitation	adult	4–5 mg/kg	IM	not captured	standing	pages 37, 39 · source
Severe pain	adult	0.15 mg/kg	IV	not captured	standing	pages 83, 140 · source

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	20–50 mg	IO	not captured	standing	pages 266, 268 · source
Mild to moderate pain	peds	0.5 mg/kg	IO	not captured	standing	pages 266, 268 · source
RSI induction	adult	1 mg/kg	IV	not captured	standing	pages 182, 207 · source
RSI induction	peds	1 mg/kg	IV	not captured	standing	pages 182, 207 · source
Wide-complex tachycardia	adult	1–1.5 mg/kg	IV	not captured	standing	page 323 · source
Wide-complex tachycardia	peds	1 mg/kg	IV	not captured	standing	page 323 · source

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	2–4 mg	IV/IM	not captured	standing	pages 91, 92 · source
Procedural sedation	adult	1 mg	IV	not captured	standing	page 65 · source
Procedural sedation	adult	2 mg	IM	not captured	standing	page 65 · source
Seizure	adult	4 mg	IV/IO	not captured	standing	pages 96, 147 · source
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 96, 147 · source

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	page 74 · source
Seizure	peds	4 g	IV	not captured	standing	pages 96, 325 · source
Wide-complex tachycardia	adult	1–2 g	IV/IO	not captured	standing	pages 124, 325 · source
Wide-complex tachycardia	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 124, 325 · source

Methylene Blue

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 mg/kg	IV	not captured	standing	pages 397, 416 · source
Other	peds	1–2 mg/kg	IV	not captured	standing	pages 397, 416 · source

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	pages 112, 161 · source
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 112, 161 · source
Allergic reaction	adult	125 mg	IV	not captured	standing	pages 73, 133 · source
Allergic reaction	peds	1 mg/kg	IV	not captured	standing	pages 73, 133 · source
Asthma / bronchospasm	adult	125 mg	IV	not captured	standing	page 135 · source
Asthma / bronchospasm	peds	1 mg/kg	IV	not captured	standing	page 135 · source

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IM	not captured	standing	pages 37, 39 · source
Agitation	adult	2.5–5 mg	IV	not captured	standing	pages 35, 39 · source
Agitation	adult	5 mg	IV	not captured	standing	pages 37, 39 · source
Agitation	adult	5–10 mg	IM	not captured	standing	pages 35, 39 · source
Procedural sedation	adult	2.5 mg	IV	not captured	standing	page 65 · source
Seizure	adult	10 mg	IM	not captured	standing	page 96 · source
Seizure	adult	5 mg	IV/IO	not captured	standing	page 96 · source
Seizure	peds	5 mg	IM	not captured	standing	page 96 · source
Narrow-complex tachycardia	adult	2.5 mg	IV	not captured	standing	page 67 · source

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	4 mg	IV	not captured	standing	page 60 · source
Severe pain	adult	4–8 mg	IV/IO	not captured	standing	page 81 · source
Severe pain	adult	4–8 mg	IV/IM	not captured	standing	pages 83, 140 · source
Severe pain	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 83, 140 · source
Severe pain	peds	0.1 mg/kg	IV	not captured	standing	page 138 · source

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IV/IM/SQ	not captured	standing	pages 86, 110, 142 · source
Opioid overdose	adult	2–4 mg	IN	not captured	standing	pages 85, 110, 141 · source
Opioid overdose	peds	0.1 mg/kg	IN	not captured	standing	pages 85, 110, 141 · source
Opioid overdose	peds	0.1 mg/kg	IV/IM/SQ	not captured	standing	pages 86, 110, 142 · source

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	2.1 mg	IM	not captured	standing	pages 331, 410 · source

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.3–0.4 mg	SL	not captured	standing	page 335 · source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 70 · source

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–30 mcg	IV	not captured	standing	pages 163, 338, 340 · source

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	4–8 mg	IV/PO	not captured	standing	page 73 · source
Allergic reaction	peds	0.1 mg/kg	IV/PO	not captured	standing	page 73 · source
Nausea / vomiting	adult	4 mg	IV	not captured	standing	page 149 · source
Nausea / vomiting	adult	4–8 mg	PO/ODT	not captured	standing	page 149 · source
Nausea / vomiting	peds	0.1 mg/kg	IV	not captured	standing	page 149 · source
Nausea / vomiting	peds	2 mg	PO/ODT	not captured	standing	page 149 · source

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	Sipped slowly until clinical improvement noted	PO	not captured	standing	pages 75, 315 · source
Hypoglycemia	peds	Sipped slowly until clinical improvement noted	PO	not captured	standing	pages 75, 315 · source

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	1–2 g	IV	not captured	standing	pages 142, 343, 402, 409 · source
Organophosphate poisoning	peds	20–40 mg/kg	IV	not captured	standing	pages 142, 343, 402, 409 · source

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20–50 mg	IV	not captured	standing	pages 69, 344 · source
Other	peds	2–6 mg/kg	IV	not captured	standing	pages 69, 344 · source

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	2.5 mg	IV	not captured	standing	page 80 · source
Nausea / vomiting	adult	5 mg	IM	not captured	standing	page 80 · source

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5 mg	IV	not captured	standing	page 80 · source
Nausea / vomiting	adult	12.5 mg	IM	not captured	standing	page 80 · source

Proparacaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 drop	not captured	not captured	standing	page 348 · source

Pyridoxine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	25 mg/kg	IV	not captured	standing	pages 406, 425 · source
Other	peds	25 mg/kg	IV	not captured	standing	pages 406, 425 · source

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.2 mg/kg	IV	not captured	standing	page 240 · source
RSI induction	peds	1.2 mg/kg	IV	not captured	standing	page 240 · source

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 mEq/kg	IV	not captured	standing	pages 86, 124 · source
Hyperkalemia	peds	1 mEq/kg	IV	not captured	standing	pages 86, 124 · source
Other	adult	1 mEq/kg	IV	not captured	standing	page 345 · source
Other	peds	1 mEq/kg	IV	not captured	standing	page 345 · source
Tricyclic overdose	adult	1 mEq/kg	IV	not captured	standing	pages 86, 142 · source
Tricyclic overdose	peds	1 mEq/kg	IV	not captured	standing	pages 86, 142 · source

Sodium Nitrite

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 ampule	IV	not captured	standing	page 419 · source
Other	peds	0.12–0.33 mL/kg	IV	not captured	standing	page 419 · source

Sotalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV	not captured	standing	page 69 · source

Streptokinase

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	500000–1500000 unit	IV	not captured	standing	page 346 · source

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 240 · source
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 240 · source

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.25 mg	SQ	not captured	standing	page 347 · source
Asthma / bronchospasm	adult	400 mcg	MDI	not captured	standing	page 347 · source
Asthma / bronchospasm	peds	0.01 mg/kg	SQ	not captured	standing	page 347 · source
Asthma / bronchospasm	peds	0.03–0.05 mg/kg	NEB	not captured	standing	page 347 · source

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 drop	not captured	not captured	standing	page 348 · source

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Alcohol withdrawal	adult	100 mg	IV/IM	not captured	standing	page 349 · source
Alcohol withdrawal	peds	10–25 mg	IV/IM	not captured	standing	page 349 · source
Other	adult	100 mg	IV/IM	not captured	standing	page 349 · source
Other	adult	100 mg	IV/IM	not captured	standing	page 349 · source
Other	adult	100 mg	IV/IM	not captured	standing	page 349 · source
Other	adult	100 mg	IV	not captured	standing	pages 407, 426 · source
Other	adult	100 mg	IV	not captured	standing	pages 407, 426 · source
Other	peds	10–25 mg	IV/IM	not captured	standing	page 349 · source
Other	peds	10–25 mg	IV/IM	not captured	standing	page 349 · source
Other	peds	10–25 mg	IV/IM	not captured	standing	page 349 · source
Other	peds	50 mg	IV	not captured	standing	pages 407, 426 · source
Other	peds	50 mg	IV	not captured	standing	pages 407, 426 · source

Tissue Plasminogen Activator

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	100 mg	IV	not captured	standing	page 350 · source

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV/IO	not captured	standing	page 173 · source
Other	peds	15 mg/kg	IV/IO	not captured	standing	page 173 · source

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	40 unit	IV	not captured	standing	page 351 · source

Cite this

Kentucky Board of Emergency Medical Services, United States EMS Protocol Census. 195 dose entries, effective 2025-04-30.

https://protoquiz.com/census/agencies/kentucky-board-of-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.